Atara Biotherapeutics Cash Flow Statement (2022-2025) | ATRA

Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -88.11M18.47M-84.09M-74.68M-74.77M-71.11M-69.80M-60.70M-31.75M-19.05M-21.91M-12.69M38.01M2.39M-4.30M
Depreciation and Depletion 1.50M1.40M1.10M0.90M0.90M0.90M0.90M0.90M0.90M0.70M0.60M0.50M0.30M
Share-based Compensation 14.34M14.12M14.02M11.36M11.76M12.55M11.14M9.93M8.40M6.34M6.42M5.85M4.21M2.80M1.23M
Gains from Sales and Divestitures 0.45M1.10M1.61M2.25M0.48M1.55M2.38M3.69M1.57M0.14M0.22M0.32M0.07M0.28M0.39M
Gains from Investment Securities 0.62M49.62M0.31M0.21M0.21M-1.77M0.23M0.23M0.20M0.23M0.25M
Asset Writedowns and Impairment 4.13M
Non-cash Items 47.40M43.90M0.09M0.04M35.70M31.40M23.40M29.90M23.80M18.70M0.17M8.60M6.10M2.70M
Cash from Operations -84.53M-63.96M-65.06M-56.88M-38.43M-52.80M-51.35M-50.41M-29.61M-10.64M-3.99M-24.47M-28.14M-7.32M-9.79M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.50M-0.31M-0.16M-0.05M1.20M1.25M1.27M1.06M1.05M1.05M1.09M0.93M0.85M0.96M0.89M
Depreciation & Amortization (CF) 1.59M1.40M1.40M1.25M1.21M1.20M1.21M1.21M1.39M1.33M1.23M1.10M1.79M0.24M0.04M
Change in Working Capital
Change in Receivables -0.32M-0.03M-0.39M39.97M-39.82M0.11M-0.34M33.95M1.73M-33.41M-1.09M0.15M7.39M-8.88M1.91M
Change in Inventory 1.59M3.75M2.52M-1.27M3.12M6.38M2.67M-4.77M0.16M-10.65M
Change in Account Payables -4.59M1.20M-1.38M-4.45M-1.89M-0.89M2.46M-2.81M-0.83M2.40M-3.11M2.22M-2.98M-0.08M-0.98M
Change in Accured Expenses -8.77M-0.06M1.29M0.05M-8.75M3.64M1.87M14.29M-5.81M-1.78M-2.85M-2.06M3.49M-7.53M-0.48M
Other Working Capital Changes -0.65M-50.82M40.00M-4.17M-2.85M-2.93M40.35M8.48M-15.72M-0.82M-12.24M-79.11M-14.38M-0.60M
Investing Activities
Capital Expenditures 2.60M1.42M0.13M0.04M0.40M0.50M0.28M0.04M0.13M0.03M0.09M
Sales of Property, Plant and Equipment 0.04M
Change in Acquisitions & Divestments 89.25M77.14M75.90M50.68M62.30M65.72M70.70M9.99M14.84M7.22M3.00M3.47M17.20M0.00M
Cash from Investing Activities 60.22M31.83M59.70M51.22M-6.01M49.48M70.45M9.94M14.72M7.20M-16.66M3.38M17.20M-5.07M-2.42M
Financing Activities
Other financing activities -0.10M-0.05M30.76M-0.01M
Cash from Financing Activities 19.85M1.16M-0.21M32.29M0.23M0.47M-0.21M1.51M24.14M-0.32M35.79M-0.33M-0.25M15.30M1.05M
Additional items
Change in Cash -4.46M-30.98M-5.57M26.63M-44.20M-2.84M18.89M-38.95M9.25M-3.77M15.14M-21.42M-11.19M2.92M-11.16M
Free Cash Flow -87.13M-65.38M-65.19M-56.92M-38.83M-53.30M-51.63M-50.45M-29.74M-10.67M-3.99M-24.56M-28.14M-7.32M-9.79M
Net Cash Flow -4.46M-30.98M-5.57M26.63M-44.20M-2.84M18.89M-38.95M9.25M-3.77M15.14M-21.42M-11.19M2.92M-11.16M